Identification of KRAP-expressing cells and the functional relevance of KRAP to the subcellular localization of IP3R in the stomach and kidney

Fujimoto,Takahiro; Shirasawa,Senji

doi:10.3892/ijmm.2012.1126

Identification of KRAP-expressing cells and the functional relevance of KRAP to the subcellular localization of IP3R in the stomach and kidney

Authors:
- Takahiro Fujimoto
- Senji Shirasawa
View Affiliations

Affiliations: Department of Cell Biology, Faculty of Medicine, Fukuoka University, Jonan-ku, Fukuoka 814-0180, Japan
Published online on: September 17, 2012 https://doi.org/10.3892/ijmm.2012.1126
Pages: 1287-1293
Copyright: © Fujimoto et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

KRAS-induced actin-interacting protein (KRAP), originally identified as one of the deregulated genes expressed in colorectal cancer, participates under physiological conditions in the regulation of systemic energy homeostasis and of the exocrine system. We have recently found that KRAP is a molecule associated with inositol 1,4,5-trisphosphate receptor (IP3R) and is critical for the proper subcellular localization of IP3R in the liver and the pancreas. However, the expression of KRAP and its precise function in other tissues remain elusive. In this study, we aimed to identify the KRAP-expressing cells in mouse stomach and kidneys and to examine the relevance of KRAP expression in the regulation of IP3R localization in these tissues. In the stomach, double immunohistochemical staining for KRAP and IP3R demonstrated that KRAP was expressed along with the apical regions in the mucous cells and the chief cells, and IP3R3 was dominantly co-localized with KRAP in these cells. Furthermore, IP3R2 was also co-localized with IP3R3 in the chief cells. It is of note that the proper localization of IP3R3 and IP3R2 in the chief cells and of IP3R3 in the mucous cells were significantly abrogated in KRAP-deficient mice. In the kidneys, KRAP was expressed in both the apical and the basal regions of the proximal tubular cells. Intriguingly, KRAP deficiency abrogated the localization of IP3R1 in the proximal tubular cells. Finally, co-immunoprecipitation study in the stomachs and the kidneys validated the physical association of KRAP with IP3Rs. These findings demonstrate that KRAP physically associates with IP3Rs and regulates the proper localization of IP3Rs in the mucous cells and the chief cells of the stomach and in the proximal tubular cells of the kidneys.

View Figures

View References

1	Ross CA, Danoff SK, Schell MJ, Snyder SH and Ullrich A: Three additional inositol 1,4,5-trisphosphate receptors: molecular cloning and differential localization in brain and peripheral tissues. Proc Natl Acad Sci USA. 89:4265–4269. 1992. View Article : Google Scholar
2	Sharp AH, McPherson PS, Dawson TM, Aoki C, Campbell KP and Snyder SH: Differential immunohistochemical localization of inositol 1,4,5-trisphosphate- and ryanodine-sensitive Ca²⁺ release channels in rat brain. J Neurosci. 13:3051–3063. 1993.PubMed/NCBI
3	Sugiyama T, Yamamoto-Hino M, Miyawaki A, Furuichi T, Mikoshiba K and Hasegawa M: Subtypes of inositol 1,4,5-trisphosphate receptor in human hematopoietic cell lines: dynamic aspects of their cell-type specific expression. FEBS Lett. 349:191–196. 1994. View Article : Google Scholar : PubMed/NCBI
4	Newton CL, Mignery GA and Südhof TC: Co-expression in vertebrate tissues and cell lines of multiple inositol 1,4,5-trisphosphate (InsP3) receptors with distinct affinities for InsP3. J Biol Chem. 269:28613–28619. 1994.PubMed/NCBI
5	Wojcikiewicz RJ: Type I, II, and III inositol 1,4,5-trisphosphate receptors are unequally susceptible to down-regulation and are expressed in markedly different proportions in different cell types. J Biol Chem. 270:11678–11683. 1995. View Article : Google Scholar : PubMed/NCBI
6	Jayaraman T, Ondriasová E, Ondrias K, Harnick DJ and Marks AR: The inositol 1,4,5-trisphosphate receptor is essential for T-cell receptor signaling. Proc Natl Acad Sci USA. 92:6007–6011. 1995. View Article : Google Scholar : PubMed/NCBI
7	Khan AA, Soloski MJ, Sharp AH, Schilling G, Sabatini DM, Li SH, Ross CA and Snyder SH: Lymphocyte apoptosis: mediation by increased type 3 inositol 1,4,5-trisphosphate receptor. Science. 273:503–507. 1996. View Article : Google Scholar : PubMed/NCBI
8	Sugawara H, Kurosaki M, Takata M and Kurosaki T: Genetic evidence for involvement of type 1, type 2 and type 3 inositol 1,4,5-trisphosphate receptors in signal transduction through the B-cell antigen receptor. EMBO J. 16:3078–3088. 1997. View Article : Google Scholar : PubMed/NCBI
9	Scharenberg AM, Humphries LA and Rawlings DJ: Calcium signalling and cell-fate choice in B cells. Nat Rev Immunol. 7:778–789. 2007. View Article : Google Scholar : PubMed/NCBI
10	deSouza N, Cui J, Dura M, McDonald TV and Marks AR: A function for tyrosine phosphorylation of type 1 inositol 1,4,5-trisphosphate receptor in lymphocyte activation. J Cell Biol. 179:923–934. 2007. View Article : Google Scholar : PubMed/NCBI
11	Patterson RL, Boehning D and Snyder SH: Inositol 1,4,5-trisphosphate receptors as signal integrators. Annu Rev Biochem. 73:437–465. 2004. View Article : Google Scholar : PubMed/NCBI
12	Bezprozvanny I: The inositol 1,4,5-trisphosphate receptors. Cell Calcium. 38:261–272. 2005. View Article : Google Scholar
13	Foskett JK, White C, Cheung KH and Mak DO: Inositol trisphosphate receptor Ca²⁺ release channels. Physiol Rev. 87:593–658. 2007. View Article : Google Scholar
14	Mikoshiba K: IP3 receptor/Ca²⁺ channel: from discovery to new signaling concepts. J Neurochem. 102:1426–1446. 2007.PubMed/NCBI
15	Zhang S, Fritz N, Ibarra C and Uhlén P: Inositol 1,4,5-trisphosphate receptor subtype-specific regulation of calcium oscillations. Neurochem Res. 36:1175–1185. 2011. View Article : Google Scholar : PubMed/NCBI
16	Inokuchi J, Komiya M, Baba I, Naito S, Sasazuki T and Shirasawa S: Deregulated expression of KRAP, a novel gene encoding actin-interacting protein, in human colon cancer cells. J Hum Genet. 49:46–52. 2004. View Article : Google Scholar : PubMed/NCBI
17	Fujimoto T, Miyasaka K, Koyanagi M, Tsunoda T, Baba I, Doi K, Ohta M, et al: Altered energy homeostasis and resistance to diet-induced obesity in KRAP-deficient mice. PLoS One. 4:e42402009. View Article : Google Scholar : PubMed/NCBI
18	Miyasaka K, Fujimoto T, Kawanami T, Takiguchi S, Jimi A, Funakoshi A and Shirasawa S: Pancreatic hypertrophy in Ki-ras-induced actin-interacting protein gene knockout mice. Pancreas. 40:79–83. 2011. View Article : Google Scholar : PubMed/NCBI
19	Fujimoto T, Koyanagi M, Baba I, Nakabayashi K, Kato N, Sasazuki T and Shirasawa S: Analysis of KRAP expression and localization, and genes regulated by KRAP in a human colon cancer cell line. J Hum Genet. 52:978–984. 2007. View Article : Google Scholar : PubMed/NCBI
20	Fujimoto T, Machida T, Tanaka Y, Tsunoda T, Doi K, Ota T, Okamura T, et al: KRAS-induced actin-interacting protein is required for the proper localization of inositol 1,4,5-trisphosphate receptor in the epithelial cells. Biochem Biophys Res Commun. 407:438–443. 2011. View Article : Google Scholar : PubMed/NCBI
21	Fujimoto T, Machida T, Tsunoda T, Doi K, Ota T, Kuroki M and Shirasawa S: Determination of the critical region of KRAS-induced actin-interacting protein for the interaction with inositol 1,4,5-trisphosphate receptor. Biochem Biophys Res Commun. 408:282–286. 2011. View Article : Google Scholar : PubMed/NCBI
22	Mills JC, Andersson N, Stappenbeck TS, Chen CC and Gordon JI: Molecular characterization of mouse gastric zymogenic cells. J Biol Chem. 278:46138–46145. 2003. View Article : Google Scholar : PubMed/NCBI
23	Zhu L, Hatakeyama J, Zhang B, Makdisi J, Ender C and Forte JG: Novel insights of the gastric gland organization revealed by chief cell specific expression of moesin. Am J Physiol Gastrointest Liver Physiol. 296:G185–G195. 2009. View Article : Google Scholar : PubMed/NCBI
24	Schubert ML: Gastric exocrine and endocrine secretion. Curr Opin Gastroenterol. 25:529–536. 2009. View Article : Google Scholar
25	Futatsugi A, Nakamura T, Yamada MK, Ebisui E, Nakamura K, Uchida K, Kitaguchi T, et al: IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism. Science. 309:2232–2234. 2005. View Article : Google Scholar : PubMed/NCBI
26	Wright SH and Dantzler WH: Molecular and cellular physiology of renal organic cation and anion transport. Physiol Rev. 84:987–1049. 2004. View Article : Google Scholar : PubMed/NCBI
27	Alrefai WA and Gill RK: Bile acid transporters: structure, function, regulation and pathophysiological implications. Pharm Res. 24:1803–1823. 2007. View Article : Google Scholar : PubMed/NCBI
28	Husain S and Thrower E: Molecular and cellular regulation of pancreatic acinar cell function. Curr Opin Gastroenterol. 25:466–471. 2009. View Article : Google Scholar : PubMed/NCBI
29	Anzai N, Jutabha P, Kanai Y and Endou H: Integrated physiology of proximal tubular organic anion transport. Curr Opin Nephrol Hypertens. 14:472–479. 2005. View Article : Google Scholar : PubMed/NCBI
30	Hernando N, Wagner CA, Gisler SM, Biber J and Murer H: PDZ proteins and proximal ion transport. Curr Opin Nephrol Hypertens. 13:569–574. 2004. View Article : Google Scholar : PubMed/NCBI
31	Brône B and Eggermont J: PDZ proteins retain and regulate membrane transporters in polarized epithelial cell membranes. Am J Physiol Cell Physiol. 288:C20–C29. 2005.PubMed/NCBI